Diagnosis and Treatment of Atopic Dermatitis in Adults and Children
A special issue of Medicina (ISSN 1648-9144). This special issue belongs to the section "Dermatology".
Deadline for manuscript submissions: 30 June 2024 | Viewed by 1643
Special Issue Editor
Special Issue Information
Dear Colleagues,
The incidence of atopic dermatitis and associated comorbidities is increasing dramatically in both children and adults worldwide. The burden of the disease on the individual and on society is also increasing. Atopic dermatitis is a disease that causes not only health problems such as itching, insomnia and increased risk of allergic reactions. The inflammation of the skin often also affects the appearance of the individual, which is particularly burdensome for adolescents and young adults, and exacerbates the disease itself through emotional distress in a positive feedback loop.
In the last decade, tremendous progress has been made in both the understanding of the etiopathogenesis and the treatment of atopic dermatitis. The focus of understanding atopic dermatitis has shifted from atopy to the breakdown of the protective skin barrier and dysregulation of the immune response, and a breakthrough in treatment has been made with the use of biologics, first in adults and in recent years in children.
With this special issue of Medicina, we aim to contribute to the understanding of atopic dermatitis as a syndrome composed of multiple phenotypes based on endotypes that differ both in the role and mode of skin barrier impairment and in the type of excessive immune response and the associated cytokines and inflammatory cells involved. In this way, we aim to identify those biomarkers of the disease that can contribute most to the personalized treatment of atopic dermatitis, which is of utmost importance in the era of biologics.
This special issue welcomes both original and review scientific articles addressing the epidemiology, an etiopathogenesis, diagnosis and treatment of atopic dermatitis and related comorbidities in adults and children.
Dr. Vojko Berce
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Medicina is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 1800 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- atopic dermatitis
- children
- adults
- etiopathogenesis
- treatment
- comorbidities
- atopy
- skin barrier
- aberrant immune response
- biologics